4//SEC Filing
Shah Gaurav 4
Accession 0001140361-25-042855
CIK 0001281895other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:05 PM ET
Size
6.0 KB
Accession
0001140361-25-042855
Insider Transaction Report
Form 4
Shah Gaurav
DirectorCEO
Transactions
- Sale
Common Stock
2025-11-18$2.98/sh−6,276$18,721→ 778,296 total
Holdings
- 207,897(indirect: By Spouse)
Common Stock
- 198,341(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001725922
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:05 PM ET
- Size
- 6.0 KB